Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2017

Aug 30, 2017

30597_dirs_2017-08-30_355a8f0d-c7b6-4861-a883-d9c3545b824c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2017-08-28

Reporting Person: THOMPSON DAVID (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-08-28 Common Stock M 19168 $3.43 Acquired 163140 Direct
2017-08-28 Common Stock M 7667 $3.43 Acquired 170807 Direct
2017-08-28 Common Stock M 15772 $8.52 Acquired 186579 Direct
2017-08-28 Common Stock M 5257 $8.52 Acquired 191836 Direct
2017-08-28 Common Stock M 4608 $10.18 Acquired 196444 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-08-28 Stock Option (right to buy) $3.43 M 19168 Disposed 2020-07-16 Common Stock (19168) Direct
2017-08-28 Stock Option (right to buy) $3.43 M 7667 Disposed 2020-07-16 Common Stock (7667) Direct
2017-08-28 Stock Option (right to buy) $8.52 M 15772 Disposed 2021-07-28 Common Stock (15772) Direct
2017-08-28 Stock Option (right to buy) $8.52 M 5257 Disposed 2021-07-28 Common Stock (5257) Direct
2017-08-28 Stock Option (right to buy) $10.18 M 4608 Disposed 2022-07-26 Common Stock (4608) Direct

Footnotes

F1: This option vested in three equal annual installments beginning on July 16, 2011.

F2: This option vested in three equal annual installments beginning on July 28, 2012.